Alebund Pharmaceuticals is an integrated biopharmaceutical company dedicated to developing innovative therapies for renal diseases and related chronic conditions. The company focuses on advancing its pipeline of treatments, including a best-in-class iron-based phosphate binder and a first-in-class pan phosphate transporter inhibitor, while also expanding the commercial reach of its products in China and globally.
